JPMORGAN CHASE & CO - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 6 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2021$2,433,000
+0.1%
25,0000.0%0.00%
Q1 2021$2,431,000
-39.3%
25,000
-40.2%
0.00%
-100.0%
Q4 2020$4,007,000
-82.3%
41,800
-83.7%
0.00%
-80.0%
Q1 2019$22,651,000
+605.0%
257,100
+471.3%
0.01%
+400.0%
Q4 2018$3,213,000
+29.1%
45,000
+50.0%
0.00%0.0%
Q1 2018$2,488,000
+66.9%
30,000
-8.5%
0.00%
Q2 2016$1,491,000
+151.4%
32,800
+118.7%
0.00%
Q1 2016$593,00015,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 586,700$57,192,0000.02%
GROUP ONE TRADING, L.P. 36,900$3,597,0000.01%
SIMPLEX TRADING, LLC 8,100$789,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders